📢 Don’t miss the chance to present your research at APASL STC 2025 in Istanbul, taking place from 24th-26th April 2025! 🌟 Theme: New Treatments in Liver Cirrhosis 🗓️ Abstract Submission Deadline: 17th January 2025 Explore the abstract topics in the flyer or visit

Gain critical insights into the burden, trends, and future projections of liver cancer in China, Japan, and South Korea. This comprehensive analysis, based on the Global Burden of Disease Study 2021, is now published in Hepatology International. Explore the data shaping regional

🌟 Join us for APASL STC & BUILD 3.0—a prestigious conference focused on Improving Non-Transplant Outcomes in Patients with Advanced Liver Disease. 🗓️ Save the Dates: February 7-9, 2025 📍 Location: Aurika Skycity in Mumbai, India 🌐 Learn More: buildconferences.in Be part

Access to treatment is a key challenge in the elimination of hepatitis B. A new study in Hepatology International examines the pricing and affordability of HBV treatment across the Asia–Pacific region, highlighting financial barriers that impact patient care and public health

🌍 Join us at APASL STC 2025 in the vibrant city of Istanbul from April 24–26, 2025! Organized by the Asian Pacific Association for the Study of the Liver (APASL), this premier event will focus on “New Treatments in Liver Cirrhosis”, bringing together world-renowned experts to

Stay informed with the latest breakthrough in hepatology. The Kyoto Consensus on Acute-on-Chronic Liver Failure (ACLF) — a pivotal step from Asia — is now published in Hepatology International. This comprehensive article offers critical insights into the diagnosis, management,

🌏 Join us at APASL 2025 Tashkent — a global platform uniting experts to share International Experience of National Programs for the Elimination of Viral Hepatitis. 🗓️ Dates: June 4-5, 2025 📍 Location: Tashkent Be part of the conversation shaping strategies to eliminate viral

Unlock new insights into pediatric hepatology. A groundbreaking study in Hepatology International explores the Role of Splenic Hepatic Elastography Ratio in distinguishing Non-Cirrhotic Portal Fibrosis (NCPF) from Chronic Liver Disease (CLD) in children and adolescents —

📢 New insights into Lean-MAFLD A comprehensive systematic review and meta-analysis in Hepatology International examines the global prevalence, metabolic characteristics, and outcomes of Lean-MAFLD, shedding light on this emerging phenotype of metabolic dysfunction-associated

Explore an innovative, data-driven approach to hepatocellular carcinoma care. A new article in Hepatology International introduces an explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in HCC—paving the way for more accurate,

New evidence highlights the critical role of inflammation in liver cancer prognosis. A recent study in Hepatology International demonstrates how systemic inflammatory response markers significantly improve discrimination in prognostic models for hepatocellular carcinoma

Publishing your article open access (OA) with Springer can increase downloads, citations, and global accessibility. 🌍 Many institutions now cover OA publishing costs through agreements with Springer Nature—making it easier than ever to share your work with the world. Learn more

"The Promise of Incretin-Based Pharmacotherapies for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)" explores emerging therapeutic strategies targeting the incretin axis. This article highlights the evolving role of GLP-1 receptor agonists and related agents in

📢 Save the Date! Join global hepatology experts at APASL STC Tokyo 2025, taking place from 2–3 October 2025 at the Toshi Center Hotel, Tokyo, Japan. Chaired by Dr. Kenichi Ikejima, this focused scientific meeting will explore cutting-edge developments in liver disease research

📄 Explore the results of a Phase 1 dose escalation trial on the sequential combination of ropeginterferon alfa-2b and anti-PD-1 therapy as adjuvant treatment in HBV-related hepatocellular carcinoma (HCC). This study offers valuable insights into the safety and potential efficacy

📢 Join us at APASL STC Oncology Taiwan 2025! 📅 5–7 September 2025 📍 Taipei Marriott Hotel, Taiwan This year's theme, "Multifaceted Approach and Treatment for Liver Cancer," will bring together leading experts to share the latest advancements in liver oncology. Don't miss

A new article in Hepatology International examines emerging therapies for HBsAg seroclearance, with a focus on innovative novel combination strategies that hold promise for functional cure. This comprehensive review offers critical insights for clinicians and researchers alike.

🌍 Join us for APASL 2025 Moscow – STC on Alcoholic Liver Disease, an international platform dedicated to the latest advances in research, prevention, and treatment of alcoholic liver disease. 📅 Coming this September 2025 We are excited to welcome leading experts, clinicians,

Explore the latest evidence on achieving a functional cure for hepatitis B virus with emerging antiviral therapies in this comprehensive systematic review and meta-analysis. This article evaluates the efficacy and potential of novel treatment strategies that could reshape HBV

Discover how systemic inflammatory response markers enhance prognostic accuracy in hepatocellular carcinoma (HCC). This study presents important findings that improve current risk stratification models and support more precise clinical decision-making. 📖 Read the full article: